Immunogenicity and Therapeutic Effects of pVAX1-rv1419 DNA from Mycobacterium tuberculosis

E-ISSN： 1875-5631|16|4|249-255

ISSN： 1566-5232

Source： Current Gene Therapy, Vol.16, Iss.4, 2016-12, pp. : 249-255

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mycobacterium tuberculosis DNA Gyrase as a Target for Drug Discovery

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 7, Iss. 2, 2007-01 ,pp. : 159-168

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging therapeutic targets in tuberculosis: eradication of thecausative agent Mycobacterium tuberculosis

By Smith P.W. Duncan K.

Expert Opinion on Therapeutic Targets, Vol. 2, Iss. 2, 1998-12 ,pp. : 87-105

Informa Healthcare

Access to resources Recommend Favorite

In-Silico Characterization of a Hypothetical Protein, Rv1288 of Mycobacterium tuberculosis Containing an Esterase Signature and an Uncommon LytE Domain

Current Computer - Aided Drug Design, Vol. 13, Iss. 2, 2017-04 ,pp. : 101-111

Bentham Science Publishers

Access to resources Recommend Favorite

High-dose flu vax induces immunogenicity in elderly

Inpharma, Vol. 1, Iss. 1617, 2007-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Structural Biology and Biochemistry of Cytochrome P450 Systems in Mycobacterium tuberculosis

By McLean Kirsty Munro Andrew

Drug Metabolism Reviews, Vol. 40, Iss. 3, 2008-07 ,pp. : 427-446

Informa Healthcare

Access to resources Recommend Favorite